• Español
Logotipo BioKeralty
  • Home
  • BioKeralty
  • Contact
/ Key role of BioKeralty in the NoCanTher project which tests the implementation of magnetic nanoparticles in the treatment of pancreatic cancer

Key role of BioKeralty in the NoCanTher project which tests the implementation of magnetic nanoparticles in the treatment of pancreatic cancer

Feb 25 2021
adminbk 0 Comments

Biokeralty news

Key role of BioKeralty in the NoCanTher project which tests the implementation of magnetic nanoparticles in the treatment of pancreatic cancer

The project aims to demonstrate the applicability of nanoparticles in the treatment of pancreatic cancer as an alternative therapy to chemotherapy

The scheme symbolizes hyperthermia, the technique analyzed by the NoCanther project to treat of pancreatic cancer.

February 25, 2021

In the absence of useful therapies for any type of patients, the NoCanTher project seeks to demonstrate the applicability of nanoparticles in the treatment of pancreatic cancer. Having BioKeralty as sponsor, the clinical study was the last stage of the European NoCanTher project, an initiative started in 2016 and funded by the European Union’s Horizon 2020 research and innovation program. To this aim, the clinical study has been based on the results obtained in the preclinical stage where BioKeralty played a key role. BioKeralty’s research was focused on the development of magnetic iron nanoparticles able to produce magnetic hyperthermia so that the heat created by these nanoparticles could be applied to sensitize cancer cells to the standard care, or even, destroy them.

Hyperthermia transforms electromagnetic energy into heat, which, combined with standard chemotherapy, destroys tumor cells while controlling the growth of the local tumor. Despite being a relatively new field of research, this approach may be a feasible option for cancer patients (especially those who do not respond to the standard treatment and in whom radiation therapy is particularly invasive).


Nanomedicine could become an alternative therapy to palliative chemotherapy to treat locally advanced pancreatic cancer cases


In this context, BioKeralty has tested this new approach in patients with locally advanced pancreatic cancer, analyzing the potential of magnetic nanoparticles to destroy tumor cells in those people with locally advanced pancreatic cancer. Consequently, nanomedicine could become an alternative therapy to palliative chemotherapy in the treatment of locally advanced, unresectable and non-metastasized pancreatic cancer.

Under the coordination of Instituto Madrileño de Estudios Avanzados (IMDEA) – Nanonciencia, currently BioKeralty continues working together with other ten national and international research centers in the implementation of nanomedicine in early clinical phases of multimodal cancer therapy.

BioKeralty present in the European project Smart4Fabry final round table next February 3

Prev Post

Completion of OSASUKAT, a blockchain platform project with a system designed by BioKeralty

Next Post
More news
BioKeralty develops a predictive software for diabetes and cognitive impairment
by adminbk 07/30/2021
Completion of OSASUKAT, a blockchain platform project with a system designed by BioKeralty
by adminbk 07/26/2021
Key role of BioKeralty in the NoCanTher project which tests the implementation of magnetic nanoparticles in the treatment of pancreatic cancer
by adminbk 02/25/2021
BioKeralty present in the European project Smart4Fabry final round table next February 3
by adminbk 01/11/2021
130 companies apply to INNO4COV-19, a project of which BioKeralty is already a partner
by adminbk 11/15/2020

Scientific resources

Patents and publications

For those people interested in the scientific publications and patents developed by the BioKeralty team, this section gathers detailed information and useful references corresponding to its scientific research.

Nanomaterials, biomedical applications, in vitro and in vivo antimicrobial activities, nanomedicine, fatty acids, nanofibrous membranes, tissue reparations, etc. constitute some of the research topics included in this section.

Awesome Image

  • C/Albert Einstein 25, Edificio E-3, 1ª planta Oficina 2

    Parque Tecnológico de Álava,

    01510 Miñano, Vitoria-Gasteiz (Álava), España

  • BioKeralty
  • Legal
  • Privacy policy
  • Cookies policy
  • Contact

Copyright © BioKeralty 2022

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

BIOKERALTY
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.